Lupus Nephritis
Watchlist
Retrieved
2022-04-26
Source
Trials
—
Genes
FCGR3B,
MMP9,
MMP2,
SERPING1,
SNRPE,
CCL2,
NLRP3,
IGAN1,
CAMK1D,
NIN,
SCARB1,
IL17A,
IL6,
TNFSF13B,
ACE,
BARX2,
TNF,
SLC5A11,
FCGR3A,
TGFB1,
IFNG,
IL10,
CXCL10,
IL18,
HLA-DRB1,
HMGB1,
MIR146A,
TLR9,
FOXP3,
STAT3
FCGR3B,
MMP9,
MMP2,
SERPING1,
SNRPE,
CCL2,
NLRP3,
IGAN1,
CAMK1D,
NIN,
SCARB1,
IL17A,
IL6,
TNFSF13B,
ACE,
BARX2,
TNF,
SLC5A11,
FCGR3A,
TGFB1,
IFNG,
IL10,
CXCL10,
IL18,
HLA-DRB1,
HMGB1,
MIR146A,
TLR9,
FOXP3,
STAT3,
CCR5,
CP,
SERPINE1,
LCN2,
TNFRSF12A,
IFNA1,
IFNA13,
VDR,
APOL1,
VEGFA,
ITGAM,
CRP,
IL1B,
C3,
TLR7,
FCGR2B,
FCGR2A,
NFE2L2,
TNFSF4,
CD40,
CD40LG,
CXCL13,
CFH,
VCAM1,
IL23A,
GABPA,
NOS3,
UCHL1,
IL2,
PDCD1,
ADIPOQ,
SPP1,
DNASE1,
TNFSF12,
MTOR,
IRF5,
IL4,
ICAM1,
TNFSF12-TNFSF13,
TLR4,
CCL5,
IL34,
CAMK4,
BTK,
MIR150,
TRAF6,
IL22,
IL37,
PTX3,
MIR663A,
FOXO1,
IRAK1,
STAT1,
ESR1,
MAPK1,
ACTB,
FN1,
TNFAIP3,
FCN2,
TLR3,
CXCR3,
MIR423,
CD80,
ITGB2,
BCL2,
CXCR5,
RHBDF2,
PLAAT4,
ANXA2,
KRT20,
CALR,
MS4A1,
HAVCR1,
TNFSF13,
ALB,
MIR21,
CABIN1,
MPO,
REN,
AGT,
MX1,
KLK4,
ATG5,
PTGS2,
SERPINA3,
PTGDS,
PSMB8,
PRTN3,
PODXL,
PHYH,
MYH9,
COX2,
MEFV,
LGALS3,
KLK1,
ITGAE,
MT1B,
FCN3,
CCL17,
CXCL12,
DDX58,
RNF19A,
POLDIP2,
CD274,
IL21,
BAGE3,
IL33,
IL17F,
TNFRSF13C,
RBM45,
EMB,
MIR130B,
MIR145,
MIR155,
MIR198,
MIR29C,
MIR371A,
MIR485,
CCR2,
TNFRSF13B,
DKK1,
PLA2R1,
SOCS1,
TRIM21,
STAT4,
AURKA,
TLR2,
TLR5,
TNFRSF4,
AIMP2,
TAM,
MTMR3,
FSTL1,
GRAP2,
AIM2,
RAPGEF5,
HDAC6,
IL18BP,
TNIP1,
ANP32B,
AHSA1,
ISG20,
MTCO2P12,
DDR1,
CASP3,
CRK,
ABCD1,
MAPK14,
GATA3,
BGN,
GC,
ENO1,
GAS6,
COL1A1,
CST3,
HLA-DQA1,
AKT1,
CTNNB1,
CLU,
DNASE1L3,
CYP2B6,
IL13,
IL2RA,
DECR1,
CD34,
CCT,
ANKRD1,
ENTPD1,
IL17B,
CD19,
IBD5,
CD28,
CD38,
IL20,
CD86,
IRF3,
GPRC5B,
MYDGF,
AICDA,
ANKRD50,
PAK5,
C5AR1,
RETN,
ALG1,
ATF7IP,
RIPK4,
WDR11,
OTUB1,
TET2,
VPS51,
CYCS,
CLEC4E,
CD44,
SIRT1,
CD68,
CD74,
CSF1R,
MERTK,
TUBA1B,
SEMA3A,
IKZF1,
RTN3,
PSME3,
TRAP1,
CCN2,
CTLA4,
CTSS,
CX3CR1,
CYP2C19,
CYP3A5,
KL,
PROCR,
IFI44,
CSF1,
MPRIP,
DIANPH,
CDKN1A,
PADI4,
CCR1,
CXCL16,
ICOSLG,
CMKLR1,
POSTN,
NLRP1,
COL4A1,
ADAMTS13,
RIPK3,
CFHR3,
HPSE,
HAMP,
GAS5,
C5,
MIR141,
MIR323B,
AGA,
MIR422A,
WG,
AGER,
AGTR1,
AHCY,
MIR221,
MIR200C,
MIR183,
MIR182,
MIR15B,
ANGPT2,
MIR152,
AIRE,
MIR148A,
KLK3,
ADM,
MIR146B,
MT1IP,
TTC34,
MIR6741,
MIR7977,
MIR4732,
MIR4511,
MIR3942,
MIR1260B,
MIR3074,
MIR1224,
MIR584,
MIR543,
ACTN4,
POTEF,
ADD2,
MIR654,
MIR638,
MIR589,
FASLG,
ATF4,
C3AR1,
MIR125A,
ABCC11,
BLK,
HAVCR2,
FCRLA,
NT5C1A,
FAM167A,
MAP1LC3B,
CFHR5,
CMIP,
VTCN1,
C1S,
TNIP2,
IL25,
CLEC7A,
CARD9,
IFIH1,
PPIG,
ITPRIP,
TRIM15,
CFB,
BTLA,
MIR10A,
IRGM,
ZNF546,
XKR6,
IFNL3,
PCSK9,
MUC20,
AXL,
DBA2,
B2M,
BACH1,
LRRK2,
IL22RA2,
BAG1,
BAX,
BDNF,
LONP1,
MBD2,
CD163,
AIMP1,
PIK3CA,
HP,
PGM1,
PECAM1,
PDGFRA,
PDGFB,
HPX,
PCNA,
HES1,
OSM,
OGG1,
NOTCH3,
HSPE1,
NOS1,
NFKB1,
HSPG2,
NFATC1,
PIK3CB,
PIM1,
PIK3CD,
PRKAB1,
HIF1A,
PTEN,
ACR,
HLA-C,
PRL,
HLA-G,
PRKCB,
PRKAA2,
PIK3CG,
PRKAA1,
PON3,
PON2,
PON1,
HNF4A,
PMS2,
PLG,
NELL1,
HTR1A,
IFI35,
LTA,
MDM2,
MDK,
CD46,
MCL1,
MBL2,
SMAD7,
LY6E,
LGALS9,
IGHA1,
IGHG3,
LEP,
KNG1,
IL7,
JUN,
CXCL8,
IL10RA,
MECP2,
CXCL9,
MTTP,
MT1H,
MTNR1A,
IFN1@,
MT2A,
MT1X,
MT1L,
MT1M,
MT1JP,
MT1G,
IGBP1,
MT1F,
MT1E,
IFNA2,
MT1A,
IFNA17,
IFNAR1,
MMP3,
PTGS1,
HGF,
PTPRZ1,
TRAF2,
EPHX2,
EPO,
TYROBP,
ERBB2,
EXT1,
TTR,
EXT2,
TRAF1,
EPHB2,
TNFRSF1A,
F3,
PTK2B,
FBN1,
FCAR,
FCGRT,
FCN1,
EPHX1,
VIP,
FEN1,
EDN1,
IL32,
USP2,
TIMELESS,
NRP1,
ATN1,
DUSP1,
E2F2,
API5,
LAPTM5,
ELANE,
ULK1,
AXIN2,
ELAVL2,
FGF23,
ARHGEF5,
LAP,
TIMP1,
TFPI,
PTPRZ2,
S100A1,
NR3C1,
CCL3L1,
CXCL1,
SAFB,
S100B,
S100A8,
S100A4,
TRIM27,
CX3CL1,
GSTA1,
RBP4,
GSTP1,
RARRES2,
RARB,
RAC1,
GTF2I,
CCL11,
SDC2,
TRBV20OR9-2,
FLT3LG,
TAT,
ADAM17,
SYK,
ABCC8,
FGB,
FLI1,
FLII,
FOSL2,
SELE,
FTH1,
SPINK1,
SPG7,
SLC8A1,
SH3BP2,
SGK1,
SRSF1,
PSMB9
Drugs
—
Registered!
Lupus nephritis is a kidney disorder that is a complication of systemic lupus erythematous (SLE), commonly known as lupus. The symptoms of lupus nephritis include blood in the urine, a foamy appearance to the urine, high blood pressure, and swelling in any part of the body. This condition typically occurs in people aged 20 to 40 years. Treatment may involve medications to suppress the immune system, dialysis, or a kidney transplant.
Visit our Web page on lupus for more information and resources.
Visit our Web page on lupus for more information and resources.